Business Description
Enzymatica AB
NAICS : 325412
SIC : 2834
ISIN : SE0003943620
Compare
Compare
Traded in other countries / regions
ENZY.SwedenEN9.Germany IPO Date
2015-06-15Description
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.46 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.38 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.51 | |||||
| Beneish M-Score | -3.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.4 | |||||
| 3-Year EBITDA Growth Rate | -89.1 | |||||
| 3-Year EPS without NRI Growth Rate | -49.4 | |||||
| 3-Year FCF Growth Rate | -32.3 | |||||
| 3-Year Book Growth Rate | -14.5 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.46 | |||||
| 9-Day RSI | 32.52 | |||||
| 14-Day RSI | 39.18 | |||||
| 6-1 Month Momentum % | -21.41 | |||||
| 12-1 Month Momentum % | 35.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.84 | |||||
| Cash Ratio | 0.26 | |||||
| Days Inventory | 225.92 | |||||
| Days Sales Outstanding | 75.78 | |||||
| Days Payable | 86.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.8 | |||||
| Shareholder Yield % | -2.57 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.59 | |||||
| Operating Margin % | -94.42 | |||||
| Net Margin % | -97.69 | |||||
| FCF Margin % | -80.58 | |||||
| ROE % | -48.91 | |||||
| ROA % | -33.78 | |||||
| ROIC % | -41.73 | |||||
| ROC (Joel Greenblatt) % | -259.48 | |||||
| ROCE % | -38.75 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 9.99 | |||||
| PB Ratio | 6.63 | |||||
| Price-to-Tangible-Book | 61.6 | |||||
| EV-to-EBIT | -11.42 | |||||
| EV-to-Forward-EBIT | -54.32 | |||||
| EV-to-EBITDA | -11.42 | |||||
| EV-to-Forward-EBITDA | -60.35 | |||||
| EV-to-Revenue | 10.68 | |||||
| EV-to-Forward-Revenue | 5.08 | |||||
| EV-to-FCF | -14.57 | |||||
| Price-to-Median-PS-Value | 1.07 | |||||
| Earnings Yield (Greenblatt) % | -8.74 | |||||
| FCF Yield % | -7.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzymatica AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 50.904 | ||
| EPS (TTM) (kr) | -0.3 | ||
| Beta | 0.11 | ||
| Volatility % | 41.15 | ||
| 14-Day RSI | 39.18 | ||
| 14-Day ATR (kr) | 0.258985 | ||
| 20-Day SMA (kr) | 3.479 | ||
| 12-1 Month Momentum % | 35.62 | ||
| 52-Week Range (kr) | 2.1 - 4.425 | ||
| Shares Outstanding (Mil) | 173.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzymatica AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzymatica AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzymatica AB Frequently Asked Questions
What is Enzymatica AB(OSTO:ENZY)'s stock price today?
The current price of OSTO:ENZY is kr3.08. The 52 week high of OSTO:ENZY is kr4.43 and 52 week low is kr2.10.
When is next earnings date of Enzymatica AB(OSTO:ENZY)?
The next earnings date of Enzymatica AB(OSTO:ENZY) is 2024-07-18.
Does Enzymatica AB(OSTO:ENZY) pay dividends? If so, how much?
Enzymatica AB(OSTO:ENZY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers